机构地区:[1]Department of Neurology, Putuo Hospital,Shanghai University of Traditional Chinese Medicine [2]Department of Emergency Internal Medicine, Putuo Hospital,Shanghai University of Traditional Chinese Medicine [3]Laboratory of Neurology, Institute of Integrative Medicine,Zhongshan Hospital, Fudan University [4]Department of Integrative Medicine, Zhongshan Hospital,Fudan University [5]Center for Translational Neurodegeneration and Regenerative Therapy, Shanghai Tenth People’s Hospital Affiliated with Tongji University School of Medicine [6]Department of Immunology, Tongji University School of Medicine
出 处:《Neuroscience Bulletin》2016年第4期349-362,共14页神经科学通报(英文版)
基 金:supported by the National Natural Science Foundation of China(81202814);the Shanghai Municipal Commission of Health and Family Planning(20124y116);the Young Teachers Training Funding Scheme of Shanghai Colleges and Universities,China(zzszy12026)
摘 要:Echinacoside (ECH) is protective in a mouse model of Parkinson' s disease (PD) induced by 1-methyl-4- phenylpyridinium ion (MPP+). To investigate the mechanisms involved, SH-SYSY neuroblastoma ceils were treated with MPP+ or a combination of MPP+ and ECH, and the expression of ATF3 (activating transcription factor 3), CHOP (C/EBP-homologous protein), SCNA (synuclein alpha), and GDNF (glial cell line-derived neurotrophic factor) was assessed. The results showed that ECH significantly improved cell survival by inhibiting the generation of MPP+-induced reactive oxygen species (ROS). In addition, ECH suppressed the ROS and MPP+- induced expression of apoptotic genes (ATF3, CHOP, and SCNA). ECH markedly decreased the MPP+-induced cas- pase-3 activity in a dose-dependent manner. ATF3- knockdown also decreased the CHOP and cleaved caspase- 3 levels and inhibited the apoptosis induced by MPP+. Interestingly, ECH partially restored the GDNF expression that was down-regulated by MPP+. ECH also improved dopaminergic neuron survival during MPP+ treatment and protected these neurons against the apoptosis induced by MPTP. Taken together, these data suggest that the ROS/ ATF3/CHOP pathway plays a critical role in mechanisms by which ECH protects against MPP+-induced apoptosis in PD.Echinacoside (ECH) is protective in a mouse model of Parkinson' s disease (PD) induced by 1-methyl-4- phenylpyridinium ion (MPP+). To investigate the mechanisms involved, SH-SYSY neuroblastoma ceils were treated with MPP+ or a combination of MPP+ and ECH, and the expression of ATF3 (activating transcription factor 3), CHOP (C/EBP-homologous protein), SCNA (synuclein alpha), and GDNF (glial cell line-derived neurotrophic factor) was assessed. The results showed that ECH significantly improved cell survival by inhibiting the generation of MPP+-induced reactive oxygen species (ROS). In addition, ECH suppressed the ROS and MPP+- induced expression of apoptotic genes (ATF3, CHOP, and SCNA). ECH markedly decreased the MPP+-induced cas- pase-3 activity in a dose-dependent manner. ATF3- knockdown also decreased the CHOP and cleaved caspase- 3 levels and inhibited the apoptosis induced by MPP+. Interestingly, ECH partially restored the GDNF expression that was down-regulated by MPP+. ECH also improved dopaminergic neuron survival during MPP+ treatment and protected these neurons against the apoptosis induced by MPTP. Taken together, these data suggest that the ROS/ ATF3/CHOP pathway plays a critical role in mechanisms by which ECH protects against MPP+-induced apoptosis in PD.
关 键 词:ECHINACOSIDE Parkinson's disease 1-Methyl-4-phenylpyridinium ion. Reactive oxygen species ATF3 CHOP
分 类 号:R742.5[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...